In a regulatory filing, IGM Biosciences director M. Kathleen Behrens disclosed the purchase of 60,000 common shares of the company on November 8 at a price of $17.1425 per share.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IGMS: